健康元：公司一直积极关注AI制药领域的行业动态与合作机会

Core Viewpoint - The company is actively monitoring developments and collaboration opportunities in the AI pharmaceutical sector, aiming to integrate AI technology with innovative drug research and development across the entire industry chain [1] Group 1 - The company is exploring multidimensional AI innovative drug research and development collaborations with quality partners in the industry [1] - The company will evaluate and actively promote any strategic collaboration opportunities that align with its development goals [1] - The company commits to timely information disclosure if there are any substantial advancements in related collaborations [1]